Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!
CHEN Wei-chen, XUE Bin, LI Zhi-chen. Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(6): 449-450.
Citation:
CHEN Wei-chen, XUE Bin, LI Zhi-chen. Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(6): 449-450.
Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis
Department of Pharmacy, Nanhui Central Hospital, Pudong New District, Shanghai 201300, China
2.
Department of Surgery, Nanhui Central Hospital, Pudong New District, Shanghai 201300, China
Received Date: 2010-06-22
Rev Recd Date:
2011-09-19
Abstract
Objective To confirm the effect of gabexate mesylate on eliminating choledocholithiasis. Methods By simple randomization, the patients were assigned control group (not use gabexate), regular dosage group and high dosage group. The difference between every group on effect of eliminating choledocholithiasis by nonsurgical operation was observed. Results No significant different was found between regular dosage group and control group (P>0.05). There was a significant different between regular dosage group and high dosage group (P<0.05). Conclusion Gabexate mesylate had the effect of eliminating choledocholithiasis.
Abstract: Objective To confirm the effect of gabexate mesylate on eliminating choledocholithiasis. Methods By simple randomization, the patients were assigned control group (not use gabexate), regular dosage group and high dosage group. The difference between every group on effect of eliminating choledocholithiasis by nonsurgical operation was observed. Results No significant different was found between regular dosage group and control group (P>0.05). There was a significant different between regular dosage group and high dosage group (P<0.05). Conclusion Gabexate mesylate had the effect of eliminating choledocholithiasis.
CHEN Wei-chen, XUE Bin, LI Zhi-chen. Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(6): 449-450.
Citation:
CHEN Wei-chen, XUE Bin, LI Zhi-chen. Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(6): 449-450.
DownLoad: